Signal transduction of chemokine platelet factor 4 in human erythroleukemia cells
- PMID: 12041672
- DOI: 10.1007/BF02982132
Signal transduction of chemokine platelet factor 4 in human erythroleukemia cells
Abstract
Previous data have demonstrated that CXC-chemokine platelet factor 4 (PF4) inhibits the proliferation of the human erythroleukemia cell line (HEL). However, the mechanism of action is unclear at present. The signaling transduction induced by PF4 in the HEL was compared with that induced by transforming growth factor beta1 (TGF-beta1), which is also a potent inhibitor of HEL growth. It was found that PF4 had no inhibitory effect on intracellular calcium levels in resting HEL cells. When HEL cells were stimulated with interleukin-3 (IL-3), a rapid increase in the intracellular level of free calcium occurred within 15 to 20 seconds, and this increase was followed by a sustained increase that gradually declined until resting levels were reached 30 to 40 minutes later. PF4 dramatically decreased the transient rise of [Ca2+] and protein kinase C (PKC) activity of HEL cells induced by IL-3. However, PF4 had no inhibitory effect on PKC activation in resting HEL cells. Furthermore, PF4 was found to down-regulate significantly protein tyrosine kinase (PTK) activity. In contrast, TGF-beta1 induced an increase in intracellular free calcium concentration and PKC and PTK activity in HEL cells. Furthermore, PF4 significantly increased the messenger RNA (mRNA) level of p21waf1 in HEL cells. These data demonstrate that PF4 acts on HEL cells through a signaling transduction pathway, which is different from that of TGF-beta1 and is related to the up-regulatory mRNA level of p21waf1 in HEL cells.
Similar articles
-
Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.J Lab Clin Med. 1992 Oct;120(4):645-60. J Lab Clin Med. 1992. PMID: 1402341
-
Inhibitory effect of platelet factor 4 on human erythroleukemic cells is dependent on cell surface heparan sulfate.J Lab Clin Med. 1996 Apr;127(4):382-90. doi: 10.1016/s0022-2143(96)90186-9. J Lab Clin Med. 1996. PMID: 8656041
-
Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.Exp Hematol. 2001 May;29(5):602-8. doi: 10.1016/s0301-472x(01)00628-2. Exp Hematol. 2001. PMID: 11376873
-
Selection of an HEL-derived cell line expressing high levels of platelet factor 4.Blood. 1993 Jun 1;81(11):2885-90. Blood. 1993. PMID: 8499627
-
[Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].Bull Acad Natl Med. 1995 Nov;179(8):1657-70. Bull Acad Natl Med. 1995. PMID: 8717183 French.
Cited by
-
Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma.Haematologica. 2013 Feb;98(2):288-95. doi: 10.3324/haematol.2012.065607. Epub 2012 Aug 28. Haematologica. 2013. PMID: 22929979 Free PMC article.
-
Platelet factor 4 protects bone marrow mesenchymal stem cells from acute radiation injury.Br J Radiol. 2014 Aug;87(1040):20140184. doi: 10.1259/bjr.20140184. Epub 2014 Jun 12. Br J Radiol. 2014. PMID: 24922360 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous